Medical School
- MD, University of Colorado School of Medicine
Undergraduate School
- BS, University of California–San Diego (CA)
Residency
- University of Colorado, Internal Medicine
Fellowships
- University of Colorado, Hematology and Oncology
Department
Medicine-Medical OncologyResearch Interests
Translational research and clinical trials for the treatment of breast cancerPublications
- Schreiber AR, Smoots SG, Jackson MM, Bagby SM, Dus ED, Dominguez ATA, Binns CA, Pitts TM, Diamond JR. Potentiating doxorubicin activity through BCL-2 inhibition in p53 wild-type and mutated triple-negative breast cancer. Front Oncol. 2025;15:1549282. PubMed PMID: 40242242
- Smoots SG, Schreiber AR, Jackson MM, Bagby SM, Dominguez ATA, Dus ED, Binns CA, MacBeth M, Whitty PA, Diamond JR, Pitts TM. Overcoming doxorubicin resistance in triple-negative breast cancer using the class I-targeting HDAC inhibitor bocodepsin/OKI-179 to promote apoptosis. Breast Cancer Res. 2024 Mar 1;26(1):35. PubMed PMID: 38429789
- Schreiber AR, Kagihara JA, Corr BR, Davis SL, Lieu C, Kim SS, Jimeno A, Camidge DR, Williams J, Heim AM, Martin A, DeMattei JA, Holay N, Triplett TA, Eckhardt SG, Litwiler K, Winkler J, Piscopio AD, Diamond JR. First-in-Human Dose-Escalation Study of the Novel Oral Depsipeptide Class I-Targeting HDAC Inhibitor Bocodepsin (OKI-179) in Patients with Advanced Solid Tumors. Cancers (Basel). 2023 Dec 23;16(1). PubMed PMID: 38201519
- Schreiber AR, Kagihara J, Eguchi M, Kabos P, Fisher CM, Meyer E, Molina E, Kondapalli L, Bradley CJ, Diamond JR. Evaluating anthracycline?+?taxane versus taxane-based chemotherapy in older women with node-negative triple-negative breast cancer: a SEER-Medicare study. Breast Cancer Res Treat. 2022 Jan;191(2):389-399. PubMed PMID: 34705147
Practice Locations
UCHealth University of Colorado Hospital (UCH)12605 E. 16th Ave
Aurora, CO 80045
720-848-0000
Specialty Information
Specialties- Medical Oncology
Clinical Interests
I treat patients with all stages of breast cancer using conventional and clinical trial treatment options. My goal is to support my patients and their families by delivering comprehensive and compassionate care.
I treat patients with all stages of breast cancer using conventional and clinical trial treatment options. My goal is to support my patients and their families by delivering comprehensive and compassionate care.